Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N- methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein

Molecular Carcinogenesis

Volumn 27, Issue 4, 2000, Pages 298-307

  Rehman, Ishtiaq ^a   Lowry, David T ^a   Adams, Cameron ^a   Abdel Fattah, Rana ^a   Holly, Alesia ^a   Yuspa, Stuart H ^a   Hennings, Henry ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Keratoacanthoma; Papilloma; Progression; Promotion; Squamous cell carcinoma

Indexed keywords

METHYLNITRONITROSOGUANIDINE; MEZEREIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE MUTATION; KERATOACANTHOMA; MOUSE; NONHUMAN; ONCOGENE; PAPILLOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CODON; DITERPENES; DNA PRIMERS; FEMALE; GENES, RAS; METHYLNITRONITROSOGUANIDINE; MICE; MUTAGENS; MUTATION; PAPILLOMA; SKIN NEOPLASMS; TERPENES;

ANIMALIA;

EID: 0034078146     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200004)27:4<298::AID-MC8>3.0.CO;2-4     Document Type: Article

References (43)

1. Yuspa SH The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 1994;54:1178-1189.
2. Balmain A, Ramsden M, Bowden GT, Smith J Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 1984;307:658-660.
3. Fujiki H, Suganuma M, Yoshizawa S, et al. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters. Mol Carcinog 1989;2:184-187.
4. Kim TW, Porter KL, Foley JF, Maronpot RR, Smart RC. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype. Mol Carcinog 1997;20:115-124.
5. Pelling JC, Fischer SM, Neades R, Strawhecker J, Schweickert L. Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents. Carcinogenesis 1987;8:1481-1484.
6. Hennings H, Devor D, Wenk ML, et al. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N′-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res 1981;41:773-779.
7. Brown K, Buchmann A, Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc Natl Acad Sci USA 1990;87:538-542.
8. Hennings H, Shores R, Mitchell P, Spangler EF, Yuspa SH. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 1985;6: 1607-1610.
9. Hennings H, Boutwell RK. The inhibition of DNA synthesis by initiators of mouse skin tumorigenesis. Cancer Res 1969; 29:510-514.
10. Hennings H, Michael D, Patterson E. Croton oil enhancement of skin tumor initiation by N-methyl-N′-nitro-N-nitrosoguanidine: possible role of DNA replication. Proc Soc Exp Biol Med 1978;158:1-4.
11. Knutsen GL, Kovatch RM, Robinson M. Gross and microscopic lesions in the female SENCAR mouse skin and lung in tumor initiation and promotion studies. Environ Health Perspect 1986;68:91-104.
12. Burchill SA, Neal DE, Lunec J. Frequency of H-ras mutations in human bladder cancer detected by direct sequencing. Br J Urol 1994;73:516-521.
13. Rithidech KN, Dunn JJ, Gordon CR, Cronkite EP, Bond VP. N-ras mutations in radiation-induced murine leukemic cells. Blood Cells Mol Dis 1996;22:271-280.
14. Bremner R, Kemp CJ, Balmain A. Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors. Mol Carcinog 1994;11:90-97.
15. Alagar R, Crenshaw J, Oechsil MN, Hendler FJ. 4-Nitroquinoline-1-oxide (4NQO) induces Kras mutations in murine lung adenocarcinomas and skin squamous cell carcinomas Proceedings of the American Association for Cancer Research 1998;39:533.
16. Pierceall WE, Kripke ML, Ananthaswamy HN. N-ras mutation in ultraviolet radiation-induced murine skin cancers Cancer Res 1992;52:3946-3951.
17. Megosh L, Halpern M, Farkash E, O'Brien TG. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ ODC transgenic mice. Mol Carcinog 1998;22:145-149.
18. Mufson RA, Fischer SM, Verma AK, Gleason GL, Slaga TJ, Boutwell RK. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3′:5′-monophosphate, and induction of mouse skin tumors in vivo. Cancer Res 1979;39:4791-4795.
19. Slaga TJ, Fischer SM, Nelson K, Gleason GL. Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc Natl Acad Sci USA 1980;77:3659-3663.
20. Finch JS, Albino HE, Bowden GT. Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP. Carcinogenesis 1996;17:2551-2557.
21. Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 1993;53:1625-1629.
22. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995;131:796-800.
23. Corominas M, Kamino H, Leon J, Pellicer A. Oncogene activation in human benign tumors of the skin (keratoacanthomas): Is HRAS involved in differentiation as well as proliferation? Proc Natl Acad Sci USA 1989;86:6372-6376.
24. Malkinson AM. Primary lung tumors in mice: an experimentally manipulate model of human adenocarcinoma. Cancer Res 1992;52:2670s-2676s.
25. Chiang JM, Chou YH, Chou TB. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer. Cancer Res 1998;58:3289-3293.
26. Bos JL. ras oncogenes in human cancer: A review. Cancer Res 1989;49:4682-4689.
27. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998;111:757-761.
28. Loktionov A, Hollstein M, Martel N, et al. Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA. Mol Carcinog 1990;3: 134-140.
29. Manam S, Storer RD, Prahalada S, et al. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice. Cancer Res 1992;52:3347-3352.
30. Sithanandam G, Ramakrishna G, Diwan BA, Anderson LM. Selective mutation of K-ras by N-ethylnitrosourea shifts from codon 12 to codon 61 during fetal mouse lung maturation. Oncogene 1998;17:493-502.
31. Furth ME, Aldrich TH, Cordon-Cardo C Expression of ras proto-oncogene proteins in normal human tissues. Oncogene 1987;1:47-58.
32. Leon J, Guerrero I, Pellicer A. Differential expression of the ras gene family in mice. Mol Cell Biol 1987;7:1535-1540.
33. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R. The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 1995;92: 1709-1713.
34. Johnson L, Greenbaum D, Cichowski K, et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras [erratum appeared in Genes Dev 1997 Dec 1;11(23):3277]. Genes Dev 1997;11:2468-2481.
35. Thompson TA, Kim K, Gould MN. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland. Cancer Res 1998;58:5097-5104.
36. Yan J, Roy S, Apolloni A, Lane A, Hancock JF. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 1998;273:24052-24056.
37. Voice JK, Klemke RL, Le A, Jackson JH. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem 1999;274:17164-17170.
38. Furstenberger G, Hecker E. Zum Wirkungsmechanismus cocarcinogener. Title: Mode of action of cocarcinogenic plant components [Article in German]. Planta Medica 1972; 22:241-266.
39. Klein-Szanto AJ, Conti CJ, Aldaz CM, Clapp N, Nesnow S, Slaga TJ. Effects of chronic topical application of 12-O-tetradecanoylphorbol-13-acetate on the skin and internal organs of SENCAR mice. Environ Health Perspect 1986; 68:75-80.
40. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993;291:329-343.
41. Wang QJ, Bhattacharyya DK, Garfield S, Marquez VE, Blumberg PM. Differential localization of protein kinase Cδ by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J Biol Chem 1999, In Press.
42. Chiloeches A, Paterson HF, Marais R, Clerk A, Marshall CJ, Sugden PH. Regulation of Ras. GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. Activation of the extracellular signal-regulated kinase cascade by phorbol ester is mediated by Ras J Biol Chem 1999;274:19762-19770.
43. Cesen-Cummings K, Warner KA, Ruch RJ. Role of protein kinase C in the deficient gap junctional intercellular communication of K-ras-transformed murine lung epithelial cells Anticancer Res 1998;18:4343-4346.